INSTITUTION'S PROFILE
Global Development, Amgen, Thousand Oaks, CA, USA.
Publications (1)
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.
Journal: European journal of preventive cardiology
Publication date: 2024
Journal: European journal of preventive cardiology
Publication Year: 2024